The Missouri HealthNet Division introduces a new care model that utilizes the Unite Us Payments solution to create sustainability for…
Toronto, Ontario--(Newsfile Corp. - February 14, 2024) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") is pleased…
A Groundbreaking Formula for Health and VitalityOCALA, FL / ACCESSWIRE / February 14, 2024 / Fortifeye Vitamins, a leading provider…
A Groundbreaking Formula for Health and VitalityOCALA, FL / ACCESSWIRE / February 14, 2024 / Fortifeye Vitamins, a leading provider…
LAS VEGAS, NV / ACCESSWIRE / February 14, 2024 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI) is excited to share a promising…
KNOXVILLE, TN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that…
BOSTON, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today…
Dr. Yelena Janjigian, Chief of GI Cancers, Leads Investigator Sponsored Study at Memorial Sloan Kettering Cancer CenterTrial is Supported by…
Naporafenib is a potential first-in-class and best-in-class pan-RAF inhibitor in multiple RAS/MAPK pathway-driven tumors Initial SEACRAFT-1 Phase 1b combination data…
Up to 16 million adults in the US are living with a neurological disease, the leading cause of physical and…